{"id":"https://openalex.org/W3166285659","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-ap21","title":"Abstract AP21: A NOVEL TARGET FOR OVERCOMING ADAPTIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY IN OVARIAN CANCER","display_name":"Abstract AP21: A NOVEL TARGET FOR OVERCOMING ADAPTIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY IN OVARIAN CANCER","publication_year":2019,"publication_date":"2019-11-15","ids":{"openalex":"https://openalex.org/W3166285659","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-ap21","mag":"3166285659"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.ovcasymp18-ap21","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-ap21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.ovcasymp18-ap21","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059434798","display_name":"Yunfei Wen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yunfei Wen","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054033791","display_name":"Alpa Manchandia Nick","orcid":"https://orcid.org/0000-0001-9232-1458","observed_orcids":["https://orcid.org/0000-0001-9232-1458"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alpa M Nick","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110475785","display_name":"Gabriel Lopez\u2010Berestein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Lopez-Berestein","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111690153","display_name":"Gary E. Gallick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary E Gallick","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057720914","display_name":"Robert L Coleman Robert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert L Coleman Robert","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076834432","display_name":"Mien\u2010Chie Hung","orcid":"https://orcid.org/0000-0003-4317-4740","observed_orcids":["https://orcid.org/0000-0003-4317-4740"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mien-Chie Hung","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100640276","display_name":"Anil K. Sood","orcid":"https://orcid.org/0000-0002-5415-9901","observed_orcids":["https://orcid.org/0000-0002-5415-9901"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil K Sood","raw_affiliation_strings":["Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"22_Supplement","first_page":"AP21","last_page":"AP21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p130cas","display_name":"p130Cas","score":0.921999990940094},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy-resistance","display_name":"anti-angiogenic therapy resistance","score":0.8040000200271606},{"id":"https://openalex.org/keywords/anti-vegf-antibody","display_name":"anti-VEGF antibody","score":0.9210000038146973},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.9089999794960022},{"id":"https://openalex.org/keywords/autophagic-cell-death","display_name":"autophagic cell death","score":0.9660000205039978},{"id":"https://openalex.org/keywords/tumor-associated-endothelial-cells","display_name":"tumor endothelial cells","score":0.8399999737739563},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.722000002861023},{"id":"https://openalex.org/keywords/fak-src-signaling","display_name":"FAK/Src signaling","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6858789920806885},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6614373922348022},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6210551261901855},{"id":"https://openalex.org/C123012128","wikidata":"https://www.wikidata.org/wiki/Q5376430","display_name":"Endothelial stem cell","level":3,"score":0.4828534722328186},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4604661166667938},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45821115374565125},{"id":"https://openalex.org/C2776636583","wikidata":"https://www.wikidata.org/wiki/Q6708231","display_name":"Lymphangiogenesis","level":4,"score":0.4551205635070801},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42176973819732666},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.4161752760410309},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39158815145492554},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.321894109249115},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.31614553928375244},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18571344017982483},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.14591991901397705},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08790382742881775},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.ovcasymp18-ap21","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-ap21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.ovcasymp18-ap21","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3128695448","https://openalex.org/W2623825415","https://openalex.org/W2031863666","https://openalex.org/W4323364031","https://openalex.org/W4311864984","https://openalex.org/W2092145659","https://openalex.org/W2747510162","https://openalex.org/W2344121140","https://openalex.org/W4362541792","https://openalex.org/W2065954843"],"abstract_inverted_index":{"Abstract":[0],"Anti-angiogenic":[1],"therapy":[2,166,238,371],"such":[3],"as":[4,271,367,409],"anti-VEGF":[5],"antibody":[6],"(AVA)":[7],"has":[8],"been":[9],"being":[10],"increasingly":[11],"applied":[12],"in":[13,57,63,98,131,157,173,192,201,212,246,348,377,395],"patients":[14,36,74,378],"with":[15,37,75,86,125,155,180,288,306,338,379],"ovarian":[16,416],"cancer,":[17],"while":[18],"vast":[19],"majority":[20],"developed":[21],"adaptive":[22,374],"resistance,":[23],"highlighting":[24],"the":[25,68,150,216,223,263,319,333,357,389,400,406,458],"need":[26],"for":[27,364,404,413],"new":[28,386],"therapies.":[29],"We":[30,316],"have":[31,79,277],"screened":[32],"a":[33,54,105,184,272,279,284,299,368,410],"cohort":[34],"of":[35,104,108,122,153,187,209,231,250,266,362,392,415,457],"high-grade":[38],"serous":[39],"cancer":[40],"(HGSC)":[41],"using":[42,283],"cDNA-genomic":[43],"array":[44],"and":[45,67,136,190,239,248,303,335,341,360,399,437],"immunohistochemistry.":[46],"Our":[47,91,172],"results":[48],"indicated":[49],"that":[50,72,95,160,229,324],"p130cas":[51,78,89,154,179,211,233,270,285,394],"[Crk-associated":[52],"substrate],":[53],"central":[55],"node":[56],"FAK/Src-mediated":[58],"angiogenesis,":[59,213],"was":[60,111],"significantly":[61,80],"upregulated":[62],"tumor-associated":[64,202,251,268,396],"vascular":[65,77,88,178,210,232,269,393],"endothelium,":[66],"clinical":[69],"analysis":[70],"showed":[71,94,183],"HGSC":[73,194],"increased":[76],"shorter":[81],"disease-progression":[82],"survival":[83],"than":[84],"those":[85],"lower":[87],"levels.":[90],"cell-based":[92,320],"studies":[93,175,321,352,384],"AVA":[96,165,170,237],"treatment":[97,414],"endothelial":[99,158,203,252,314,349,397],"cells":[100,159],"led":[101],"to":[102,145,164,169,236,322,330,332,372],"internalization":[103],"100-kD":[106,120],"fragment":[107],"VEGFR2,":[109],"which":[110,254,310],"released":[112],"by":[113,242,257],"caspase-10":[114],"cleavage":[115],"from":[116],"membrane-tethered":[117],"VGFR2.":[118],"This":[119,295],"form":[121],"VEGFR2":[123],"bound":[124],"TNKS1BP1":[126],"(a":[127],"tankyrase-1-binding":[128],"protein":[129],"involved":[130],"p53-mediated":[132],"cell":[133,147,199,258],"cycle":[134],"arrest)":[135],"internalized":[137],"into":[138,143],"LC3-tagged":[139],"autophagosomes":[140,247],"or":[141],"translocated":[142],"nucleus":[144,249],"initiate":[146],"death.":[148,259],"Furthermore,":[149],"gene":[151],"ablation":[152],"CRISPR/CAS9":[156],"were":[161,255],"originally":[162],"resistant":[163],"re-sensitized":[167],"them":[168],"treatment.":[171],"vivo":[174],"on":[176,355],"targeting":[177],"host-specific":[181],"siRNA":[182],"robust":[185],"inhibition":[186],"tumor":[188],"growth":[189],"progression":[191],"orthotopic":[193],"tumors":[195],"through":[196],"initiating":[197],"autophagy-associated":[198],"death":[200],"cells.":[204,315,350],"To":[205,260],"functionally":[206],"characterize":[207],"role":[208,391],"we":[214,227,276],"established":[215],"p130casflox/flox-Tie2Cre":[217],"genomic-engineered":[218],"mice":[219],"(GEM)":[220],"model.":[221],"Using":[222],"ID8":[224],"syngeneic":[225],"model,":[226],"found":[228],"depletion":[230],"diminished":[234],"resistance":[235,375],"compromised":[240],"angiogenesis":[241],"inducing":[243],"elevated":[244],"VEGFR2/TNKS1BP1":[245],"cells,":[253],"followed":[256],"further":[261],"explore":[262],"therapeutic":[264,358,412],"potential":[265],"blocking":[267],"novel":[273,369,411],"anti-angiogenic":[274,370],"strategy,":[275],"constituted":[278],"cell-permeable,":[280],"peptide-nanoparticle":[281],"complex":[282,337],"antagonist":[286,297,327,366,408],"encapsulated":[287],"biodegradable,":[289],"long-circulating,":[290],"core-crosslinked":[291],"polymeric":[292],"micelles":[293],"(CCPM).":[294],"CCPM-p130cas":[296,326],"contains":[298],"mutated":[300],"Src-binding":[301],"domain":[302],"is":[304,328],"linked":[305],"Arg-Gly-Asp":[307],"(RGD)":[308],"peptide,":[309],"specifically":[311],"targets":[312],"angiogenic":[313,346],"also":[317],"performed":[318],"show":[323],"this":[325],"able":[329],"bind":[331],"FAK":[334],"Src":[336],"high":[339],"affinity":[340],"effectively":[342],"block":[343],"FAK/Src":[344],"mediated":[345],"property":[347],"Ongoing":[351],"are":[353],"focused":[354],"investigating":[356],"efficacy":[359],"mechanism":[361],"actions":[363],"RGD-CCPM-p130cas":[365,407],"overcome":[373],"occurred":[376],"HGSC.":[380],"In":[381],"summary,":[382],"our":[383],"provided":[385],"knowledge":[387],"regarding":[388],"pivotal":[390],"vasculature,":[398],"critical":[401],"pre-clinical":[402],"evidences":[403],"applying":[405],"cancer.":[417],"Citation":[418],"Format:":[419],"Yunfei":[420],"Wen,":[421],"Alpa":[422],"M":[423],"Nick,":[424],"G":[425],"Lopez-Berestein,":[426],"Gary":[427],"E":[428],"Gallick,":[429],"Robert":[430,433],"L":[431],"Coleman":[432],",":[434],"Mien-Chie":[435],"Hung,":[436],"Anil":[438],"K":[439],"Sood.":[440],"A":[441],"NOVEL":[442],"TARGET":[443],"FOR":[444],"OVERCOMING":[445],"ADAPTIVE":[446],"RESISTANCE":[447],"TO":[448],"ANTI-ANGIOGENIC":[449],"THERAPY":[450],"IN":[451],"OVARIAN":[452],"CANCER":[453],"[abstract].":[454],"In:":[455],"Proceedings":[456],"12th":[459],"Biennial":[460],"Ovarian":[461],"Cancer":[462,474],"Research":[463],"Symposium;":[464],"Sep":[465],"13-15,":[466],"2018;":[467],"Seattle,":[468],"WA.":[469],"Philadelphia":[470],"(PA):":[471],"AACR;":[472],"Clin":[473],"Res":[475],"2019;25(22":[476],"Suppl):Abstract":[477],"nr":[478],"AP21.":[479]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-06-22T00:00:00"}